Meyka AI API is live for developers.Start building.
Advertisement
Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc. (CYTH) Stock Overview

Explore Cyclo Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CYTH●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.72
$0.00(0.00%)
U.S. Market opens in 45h 57m
Advertisement

Cyclo Therapeutics, Inc. (CYTH)

Meyka AI Score

Z

Key Financials

Market Cap23.6M
P/E Ratio-0.59
EPS (TTM)$-0.90
ROE-7.30%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

CYTH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cyclo Therapeutics, Inc. (CYTH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.59 and a market capitalization of 23.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-12.23%
6-Month Change
-3.28%
Year-to-Date (YTD) Change
20.10%
1-Year Change
-44.14%
3-Year Change
-75.98%
5-Year Change
-95.76%
All-Time (Max) Change
-99.39%

Contact Information

https://www.cyclotherapeutics.com
386 418 8060
6714 NW 16th Street, Gainesville, FL, 32653

Company Facts

80 Employees
IPO DateMay 3, 2000
CountryUS

Frequently Asked Questions